SET SMS ALERT
BSE
Dec 12, 09:14
Dec 12, 09:14
733.10
-3.25 (-0.44%)
High
736.35
Low
733.10
High
736.00
Low
735.95
Aurobindo Pharma Ltd.
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Dec 12, 16:00
740.10
3.75 (+0.51%)
VOLUME 127,840
AVERAGE VOLUME
| 5-Day | 205,845 |
| 10-Day | 162,778 |
| 30-Day | 148,604 |
VOLUME SHOCKER
| 5-Day | 205,845 |
| 10-Day | 162,778 |
| 30-Day | 148,604 |
Prev. Close
736.35
Open Price
733.10
Bid PRICE (QTY.)
740.10 (1,000)
Offer PRICE (Qty.)
740.10 (10)
Market
Depth
Depth
Market Depth (12 Dec 2018)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 950 | 739.95 | 740.95 | 184 |
| 3000 | 738.55 | 741.00 | 103 |
| 2000 | 738.05 | 741.30 | 54 |
| 283 | 738.00 | 741.80 | 50 |
| 50 | 737.25 | 741.90 | 30 |
| 2057 | Total | 3796 | Total |
Buy Qty
2057
Sell QTY
3796
Today's Low/High
730.00
747.70
52 Wk Low/High
527.05
830.00
L/U Price Band
662.75
809.95
LIVE
NSE
Dec 12, 15:58
740.00
5.45 (+0.74%)
VOLUME 2,685,788
AVERAGE VOLUME
| 5-Day | 4,432,085 |
| 10-Day | 3,868,871 |
| 30-Day | 2,831,325 |
VOLUME SHOCKER
| 5-Day | 4,432,085 |
| 10-Day | 3,868,871 |
| 30-Day | 2,831,325 |
Prev. Close
734.55
Open Price
735.95
Bid PRICE (QTY.)
740.00 (110)
Offer PRICE (Qty.)
0.00 (0)
- Quote
- CHARTS
- NEWS
- COMMENTS16 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Track Aurobindo Pharm on the go with the moneycontrol app
Action in Aurobindo Pharma
Aurobindo Pharm
Sentimeter
91%6%3%
BUYSELLHOLD
91% of moneycontrol users recommend buying Aurobindo Pharm.
What's your call on Aurobindo Pharm today?
Read 16 investor views
Consolidated
MARKET CAP (Rs Cr)
43,363.02
P/E
19.79
BOOK VALUE (Rs)
199.39
DIV (%)
250.00%
Market Lot
1
INDUSTRY P/E
29.53
EPS (TTM)
37.39
P/C
15.78
PRICE/BOOK
3.71
DIV YIELD.(%)
0.34%
FACE VALUE (Rs)
1.00
DELIVERABLES (%)
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
COLLAPSE ALL
Top Trading Ideas
12 December 2018
buy Ceat Dec Fut |
Entry Price (Rs) 1,284.65 |
Exit Price (Rs) 1,324.00 |
Gain (Rs) 39.00 |
buy Ceat Dec Fut |
Entry Price (Rs) 1,285.00 |
Exit Price (Rs) 1,317.15 |
Gain (Rs) 32.00 |
buy GodrejConsumer Dec Fut |
Entry Price (Rs) 758.30 |
Exit Price (Rs) 775.70 |
Gain (Rs) 18.00 |
buy HexawareTech Dec Fut |
Entry Price (Rs) 333.80 |
Exit Price (Rs) 338.25 |
Gain (Rs) 4.00 |
buy TataSteel Dec Fut |
Entry Price (Rs) 510.00 |
Exit Price (Rs) 515.70 |
Gain (Rs) 6.00 |
buy ShriramTrans Dec Fut |
Entry Price (Rs) 1,160.80 |
Exit Price (Rs) 1,175.00 |
Gain (Rs) 14.00 |
buy ShriramTrans Dec Fut |
Entry Price (Rs) 1,155.00 |
Exit Price (Rs) 1,163.65 |
Gain (Rs) 9.00 |
F&O Quote
Historic Prices & Simple Moving Averages
Simple Moving Averages
| Days | BSE | NSE |
| 30 | 783.66 | 784.17 |
| 50 | 770.71 | 771.47 |
| 150 | 676.78 | 677.12 |
| 200 | 657.13 | 657.46 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Aurobindo Pharm
The pre-open session lasts for 15 minutes from 9 AM to 9:15 AM and is divided into three parts. In the first 8 minutes orders are placed. These orders can be cancelled or modified during this period. In the next 4 minutes price discovery will be done, and orders will be executed. The remaining 3 minutes are the buffer period to facilitate transition between pre open and continuous trading session.
News/Videos & Announcements
News
Announcements
Videos
Dec 11, 2018
Dec 07, 2018
Dec 06, 2018
Stock Advice & Research Reports
Stock Advice
Dec 05, 2018
Buy Aurobindo Pharma, target Rs 950: Aditya Agarwala
Nov 01, 2018
Buy Aurobindo Pharma, target Rs 925: Aditya Agarwala
Oct 31, 2018
Buy Aurobindo Pharma, target Rs 850: Abhishek Mondal
Research Reports
Financials
Income Statement
| Standalone | Sep'18 | Jun'18 | Mar'18 | Dec'17 |
| Net Sales | 3,090.38 | 2,491.62 | 2,296.32 | 2,620.35 |
| Other Income | 4.18 | 2.82 | 6.36 | 33.79 |
| PBDIT | 606.97 | 396.76 | 477.88 | 664.30 |
| Net Profit | 380.95 | 225.12 | 308.29 | 444.32 |
Balance Sheet
Mar'18
(In Rs Cr)
(In Rs Cr)
| Total Share Capital | 58.59 |
| Net Worth | 9,982.58 |
| Total Debt | 3,653.83 |
| Net Block | 3,392.97 |
| Investments | 1,967.50 |
| Total Assets | 13,636.41 |
Peers
Peer Comparison
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 431.30 | 2.25 | 678.80 | 391.10 | 103,483.03 |
| Aurobindo Pharm | 740.10 | 0.51 | 830.00 | 527.05 | 43,363.02 |
| Dr Reddys Labs | 2582.10 | -4.69 | 2745.00 | 1888.00 | 42,874.70 |
| Cipla | 530.25 | 2.02 | 678.00 | 503.95 | 42,720.60 |
| Divis Labs | 1529.20 | 3.49 | 1577.00 | 978.50 | 40,595.46 |
| More » | |||||
News on Peers & Sector
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
| Sep' 18 | Jun' 18 | Jun' 17 | Mar' 17 | |
| Promoter | 51.87 | 51.87 | 51.87 | 51.87 |
| Public (FII + DII) | 48.13 | 48.13 | 48.13 | 48.13 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
Mutual Funds Holding
| Scheme | No. of Shares |
| HDFC Balanced Advantage Fund (G) | 8,128,855 |
| HDFC Hybrid Equity Fund (G) | 5,962,188 |
| HDFC Equity Fund (G) | 4,529,480 |
| HDFC Top 100 Fund (G) | 3,172,450 |
Company Information
REGISTERED OFFICE
Address
Plot No.2, Maitri Vihar, Ameerpet,,
City
Hyderabad
State
Telangana
Pin Code
500038
Tel. No.
040-23736370 040-66725000
Fax No.
040-23747340 040-67074059
Email:
Internet
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Karvy Selenium Tower B Plot no. 31-32, Gachibowli Financial District Nanakramguda
City
Hyderabad - 500032
State
Telangana
Tel. No.
040-23001153
Fax No.
MANAGEMENT
Name
Designation
K Ragunathan
Non Executive Chairman
K Nithyananda Reddy
Vice Chairman & Whole Time Dir
N Govindarajan
Managing Director
M Sivakumaran
Whole Time Director
M Madan Mohan Reddy
Whole Time Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT
Radico Khaitan Recommended on Sep 28th 2017
Recommended price 154.00 | Peak from reco 500.00 225.63%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Aurobindo Pharm
Aurobindo Pharm is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 43,363.02 crore.
The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P Sarath Chandra Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, M Sitarama Murthy - Non Exe. & Ind. Director, Avnit Bimal Singh - Non Exe. & Ind. Director, Savita Mahajan - Addnl.Non Exe.Independent Director.
It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA.
Its Registered office is at Plot No.2, Maitri Vihar, Ameerpet,, Hyderabad,Telangana - 500038.
Their Registrars are Karvy Computershare Private Ltd.
Quick Links for Aurobindo Pharma
Related Searches
Aurobindo Pharma Stock Price, Aurobindo Pharm Stock Quote, Aurobindo Pharm Results , Aurobindo Pharm News ..
More »
Follow moneycontrol
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Live Sensex | Public Sector Banks | Market Statistics | Plan Insurance | Global Market | Business News | Mutual Fund | Best Portfolio Manager | Bse Sensex | Nse Nifty | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds |
Budget 2018 | Tax Calculator | RBI Credit Policy | News Archive | FAQs | Financial Glossary | Message Board | Moneybhai | Think India | History India | Latest News | IBNLive News | News in Hindi | Cricket News | Online Study Material | India News |Restaurants in Goa | Online Shopping in India | Cairn India | Euro | Infosys | Inflation | Silver | Glenmark Pharmaceuticals | Snapdeal | Starbucks | Narendra Modi | Crore
| Clear Study Doubts | Education Franchisee Opportunity | Rss Feeds
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Policy | Terms & Conditions | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
